Question 1

What's the Alembic Pharmaceuticals Ltd share price today?

Accepted Answer

Alembic Pharmaceuticals Ltd share price was Rs 753.45 at 04:01 PM IST on 30th Apr 2026. Alembic Pharmaceuticals Ltd share price was down by 1.08% from the previous closing price of Rs 761.65. Alembic Pharmaceuticals Ltd share price trend:

Last 1 Month: Alembic Pharmaceuticals Ltd share price moved up by 14.07% on BSE
Last 3 Months: Alembic Pharmaceuticals Ltd share price moved down by 3.40% on BSE
Last 12 Months: Alembic Pharmaceuticals Ltd share price moved down by 13.85% on BSE
Last 3 Years: Alembic Pharmaceuticals Ltd price moved up by 35.60% on BSE

Question 2

How can I quickly analyse the performance of the Alembic Pharmaceuticals Ltd stock?

Accepted Answer

The performance of the Alembic Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

The stock's PE is 23.71
Price to book value ratio is 2.79
Dividend yield of 1.46
The EPS (trailing 12 months) of the Alembic Pharmaceuticals Ltd stock is Rs 31.84

Question 3

What is the market cap of Alembic Pharmaceuticals Ltd?

Accepted Answer

Alembic Pharmaceuticals Ltd has a market capitalisation of Rs 14,809 crore.

Question 4

What is Alembic Pharmaceuticals Ltd's 52-week high/low share price?

Accepted Answer

The Alembic Pharmaceuticals Ltd’s 52-week high share price is Rs - and 52-week low share price is Rs -.

Question 5

Is the Alembic Pharmaceuticals Ltd profitable?

Accepted Answer

On a consolidated basis, Alembic Pharmaceuticals Ltd reported a profit of Rs 131.95 crore on a total income of Rs 1,891.81 crore for the quarter ended 2025. For the year ended Dec 2025, Alembic Pharmaceuticals Ltd had posted a profit of Rs 131.95 crore on a total income of Rs 1,891.81 crore.

Question 6

Which are Alembic Pharmaceuticals Ltd’s peers in the Health care sector?

Accepted Answer

Alembic Pharmaceuticals Ltd’s top 5 peers in the Health care sector are  ERIS Lifescience, Granules India, Rubicon Research, Alembic Pharma, Jubilant Pharmo, Caplin Point Lab, Alivus Life.

Question 7

Who owns how much in Alembic Pharmaceuticals Ltd?

Accepted Answer

Key changes to the Alembic Pharmaceuticals Ltd shareholding are as follows:

Promoter holding in Alembic Pharmaceuticals Ltd has gone up to 69.74 per cent as of Mar 2026 from 69.67 per cent as of Jun 2025.
Mutual Funds Uti holding in Alembic Pharmaceuticals Ltd has gone down to 8.18 per cent as of Mar 2026 from 9.05 per cent as of Jun 2025.
Insurance Companies holding in Alembic Pharmaceuticals Ltd has gone up to 7.68 per cent as of Mar 2026 from 7.01 per cent as of Jun 2025.
Indian Public holding in Alembic Pharmaceuticals Ltd has gone down to 6.86 per cent as of Mar 2026 from 7.01 per cent as of Jun 2025.
Foreign Institutional Investors holding in Alembic Pharmaceuticals Ltd has gone up to 4.25 per cent as of Mar 2026 from 3.96 per cent as of Jun 2025.
Non Institutional Investors holding in Alembic Pharmaceuticals Ltd has gone up to 2.97 per cent as of Mar 2026 from 2.89 per cent as of Jun 2025.
Other Institutional Investors holding in Alembic Pharmaceuticals Ltd has gone down to 0.29 per cent as of Mar 2026 from 0.37 per cent as of Jun 2025.
Financial Institutions holding in Alembic Pharmaceuticals Ltd has gone up to 0.03 per cent as of Mar 2026 from 0.03 per cent as of Jun 2025.
Custodians holding in Alembic Pharmaceuticals Ltd has gone up to 0.00 per cent as of Mar 2026 from 0.00 per cent as of Jun 2025.

Market Cap (₹ Cr)	14,809
Traded Value (₹ Cr)	0.30
Volume (Shares)	3,980
Face Value (₹)	2

52-Week High (₹)	-
52-Week High Date	-
52-Week Low (₹)	-
52-Week Low Date	-

All Time High (₹)	-
All Time High Date	-
All Time Low (₹)	-
All Time Low Date	-

Alembic Pharmaceuticals Share Price

Alembic Pharmaceuticals Ltd